Bioasis Technologies Inc. V.BTI

Denali trading at 35 dollars, bioasis trading at 35 cents

[Sniper007]

Man, I'm green with envy...

We need on the NASDAQ. This was a major goal for former CEO, Mark Day. Obviously, that proved more difficult than anticipated but it would seem that DrDR has big plans and the NASDAQ is likely locked firmly in her sights; we just need some more money, and I think it's coming.

I recently posted that some pharma will likely take a run at us sooner than later, but it is the bioasis shareholders that hold the cards. Do not settle for cheap 'n easy! 

Here is another reason the share price for bioasis should be multiples of 10 (maybe not this year but possibly next year or the following year):

DrDR: We have been working in a purposeful way for some time now to ensure that our xB3 technology is widely adopted where there is a need for important life-saving medicines to be effective in treating brain conditions. Some research reports have estimated that the CNS Therapeutics market could be worth $128.9 billion by 2025. Imagine its value if peripherally administered biologics were able to be effective in the brain! The market research has also indicated that the cancer component is the fastest growing CNS therapeutics market segment which is of course of great interest to Bioasis.

129 BILLION… by 2025! 

How many real players are there in this space? There are a few wannabes but there is only one true BBB vector and that is XB3. It is the most universal BBB vector out there.

Denali's market cap is currently 3.8 BILLION and the data suggests that our technology is far superior. Ugh.

Dr. Deborah Rathjen has been doing a fantastic job of promoting not only the technology but the blue-sky potential of bioasis too - finally a CEO that is making it known our potential is MASSIVE and that we are massively undervalued and underutilized. Let's cure some diseases, bioasis!

Keep up the good work DrDR.

Our time will come.

Sniper

[zwerp2000]

nice to see some posts today. bioaf has a potentially incredibly valuable platoform. chiasi gives them some confirmatiion of this. stock price is low because it's a canadian stock that many people do not know much about. the ceo suggests more data is coming so if it's positive, the stock should go higher. we need more covereage. a few more deals will also be great. it seems like all of

[fouremm]

I like seeing Denali trading at such a large market cap. To me the biggest diffence between DNLI and BTI is that DNLI is ahead from the perspective of having a few targets at early clincal stage and it is very well funded. It would seem that BTI and BTI partnerships are closing in on reaching early clincal stage for a few compounds. The DNLI market cap shows the potential valuation for BTI once

[narmac]

Correct,,,I think the Denali market cap has to do with one or more signed deals of significance under its belt. That's, if I understood DrDR correctly,,, cuz I asked her that very question a few weeks back.